InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-5.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Chang David D, Chairman & CEO. Director active across 2 companies, notably Allogene Therapeutics, Inc.. In total, 11 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €325k. Activity tracked since 24 May 2021. The latest transaction was disclosed on 14 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
46,668 shares@ US$1.964.3% of flowCommon StockSEC:0001737287-25-000042:0
46,003 shares@ US$1.683.8% of flowCommon StockSEC:0001737287-25-000017:0
552,174 shares0Common StockSEC:0001737287-25-000004:0
344,828 shares@ US$2.9046.5% of flowCommon StockSEC:0001593968-24-000714:0
53,393 shares@ US$4.3310.7% of flowCommon StockSEC:0001593968-24-000477:0
317,800 shares0Common StockSEC:0001593968-24-000192:0
1,924,464 shares0Common StockSEC:0001593968-23-000521:0
22,340 shares@ US$5.565.8% of flowCommon StockSEC:0001737287-23-000025:0
23,648 shares@ US$7.64880.024% mcap28.8% of flowCommon StockSEC:0001214659-22-004085:0
27,410 shares@ US$18.22100.0% of flowCommon StockSEC:0001214659-21-005927
27,410 shares@ US$18.220.059% mcap71.2% of flowCommon StockSEC:0001214659-21-005927:0
11 of 11 declarations
About Chang David D
David D. Chang is the President and CEO of Allogene Therapeutics, Inc. He oversees the operations and strategy of the company, bringing his expertise to foster growth and innovation.
